Ticker

Woburn, Massachusetts--(Newsfile Corp. - April 24, 2026) - iSpecimen Inc. (NASDAQ: ISPC) ("iSpecimen" or the "Company"), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today that it will effect a reverse stock split of its issued and outstanding shares of common stock, par value $0.0001 per share, as well as…

iSpecimen Inc (NASDAQ: ISPC) stock is trading higher Friday after announcing a shipping overhaul that slashes transit times by up to 85%.

Agilon Health (NYSE: AGL - Get Free Report) and iSpecimen (NASDAQ: ISPC - Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, risk, institutional ownership, profitability, valuation and earnings. Risk and Volatility Agilon Health has a beta

iSpecimen Inc. shares surge over 56% in after-hours trading after announcing faster shipping and expanded European sourcing, despite weak fourth-quarter results.

Woburn, Massachusetts--(Newsfile Corp. - April 9, 2026) - iSpecimen (NASDAQ: ISPC), an online marketplace for human biospecimens, has implemented a streamlined shipping model that enables direct shipment of biospecimens from supplier sites to customers, both domestically and internationally. By reducing reliance on centralized hub processing, the new model simplifies logistics and eliminates multi-step routing.